Skip to content

Clinical trials

Expanded access trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Switzerland Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20062

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available13
Approved for marketing8
Available3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Pfizer3
Amgen2
Bayer2
Eli Lilly and Company2
Boehringer Ingelheim1
Center Trials & Treatment1
Gilead Sciences1
Janssen-Cilag International NV1
MaaT Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
HIV Infections2
Acquired Immunodeficiency Syndrome1
COVID-191
Carcinoma, Medullary1
Colonic Neoplasms1
Colorectal Neoplasms1
Dermatitis, Atopic1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.